Laumas Sandeep
Insider CIK 1721664 · INNT Executive Chairman, Director · BTAI Director · UNCY Director · TIL CFO and CBO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-05-14 | 2026-07-28 | 47,941 | — | $0 | 47,941 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-05-14 | 2026-05-18 | 42,100 | — | $0 | 126,300 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-05-14 | 2026-05-18 | 84,200 | — | $0 | 84,200 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-05-14 | 2026-06-15 | 84,200 | — | $0 | 84,200 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-05-14 | 2026-06-15 | 42,100 | — | $0 | 126,300 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2026-05-14 | 2026-07-28 | 47,941 | — | $0 | 47,941 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| TIL Instil Bio, Inc. | M Exercise deriv | 2025-09-10 | 2025-09-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| TIL Instil Bio, Inc. | M Exercise deriv | 2025-09-10 | 2025-09-12 | 13,000 | — | $0 | 30,000 | SEC↗ |
| TIL Instil Bio, Inc. | S Sale | 2025-09-10 | 2025-09-12 | 17,539 | $23.04 | $404.1K | 12,461 | SEC↗ |
| TIL Instil Bio, Inc. | S Sale | 2025-09-10 | 2025-09-12 | 12,461 | $23.88 | $297.6K | 0 | SEC↗ |
| TIL Instil Bio, Inc. | M Exercise | 2025-09-10 | 2025-09-12 | 13,000 | $12.68 | $164.8K | 30,000 | SEC↗ |
| TIL Instil Bio, Inc. | M Exercise | 2025-09-10 | 2025-09-12 | 17,000 | $11.60 | $197.2K | 17,000 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2025-07-28 | 2025-07-30 | 21,200 | — | $0 | 41,286 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2025-04-25 | 2025-04-28 | 44,851 | — | $0 | 44,851 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2024-09-18 | 2024-09-23 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2024-02-10 | 2024-02-13 | 80,000 | — | $0 | 80,000 | SEC↗ |
| UNCY Unicycive Therapeutics, In | A Award deriv | 2023-09-05 | 2023-09-07 | 189,236 | — | $0 | 200,864 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2023-06-26 | 2023-06-28 | 17,000 | — | $0 | 17,000 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2023-01-08 | 2023-01-20 | 415,000 | — | $0 | 415,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2022-05-19 | 2022-05-23 | 17,000 | — | $0 | 17,000 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2022-03-04 | 2023-01-20 | 234,000 | — | $0 | 234,000 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2022-03-04 | 2022-03-07 | 234,000 | $8.62 | $2.02M | 234,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 14,500 | — | $0 | 14,500 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2021-05-11 | 2021-05-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2021-03-18 | 2021-03-22 | 240,000 | — | $0 | 240,000 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | A Award deriv | 2020-07-06 | 2020-07-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 424 | — | $0 | 0 | SEC↗ |
| NMTR 9 METERS BIOPHARMA, INC. | C Conversion | 2020-06-30 | 2020-07-02 | 42,400 | — | $0 | 60,400 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-04 | 424 | — | $0 | 42,400 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | P Buy deriv | 2020-05-04 | 2020-05-04 | 424 | — | $0 | 42,400 | SEC↗ |
| NMTR INNOVATE BIOPHARMACEUTICAL | A Award deriv | 2020-04-24 | 2020-05-04 | 389,294 | — | $0 | 389,294 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | A Award deriv | 2019-08-20 | 2019-08-27 | 400,000 | — | $0 | 400,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2019-06-28 | 2019-07-01 | 4,000 | $1.15 | $4.6K | 18,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2019-06-13 | 2019-06-17 | 591 | $1.22 | $721 | 14,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2019-06-13 | 2019-06-17 | 409 | $1.21 | $495 | 13,409 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2019-05-23 | 2019-05-28 | 14,700 | — | $0 | 14,700 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2019-05-22 | 2019-05-23 | 5,000 | $1.38 | $6.9K | 13,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-11-30 | 2018-12-03 | 1,000 | $2.62 | $2.6K | 7,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-11-30 | 2018-12-03 | 1,000 | $2.63 | $2.6K | 8,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-11-30 | 2018-12-03 | 1,000 | $2.64 | $2.6K | 6,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-11-29 | 2018-11-29 | 2,000 | $2.56 | $5.1K | 5,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-11-29 | 2018-11-29 | 1,000 | $2.55 | $2.5K | 3,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-09-07 | 2018-09-10 | 500 | $6.10 | $3.0K | 2,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-30 | 2018-08-30 | 500 | $5.24 | $2.6K | 750 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-28 | 2018-08-28 | 405 | $5.08 | $2.1K | 1,000 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-28 | 2018-08-28 | 95 | $5.07 | $482 | 595 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-28 | 2018-08-28 | 250 | $4.88 | $1.2K | 500 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-28 | 2018-08-28 | 0 | $4.90 | $0 | 250 | SEC↗ |
| INNT INNOVATE BIOPHARMACEUTICAL | P Buy | 2018-08-28 | 2018-08-30 | 250 | $4.90 | $1.2K | 250 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-03-13 | 37,209 | — | $0 | 124,188 | SEC↗ |